Latanotears

Latanoprost, the active ingredient in Latanotears, is a prostaglandin analog presented as eye drops for ocular use. It is prescribed to lower intraocular pressure in patients with open-angle glaucoma and ocular hypertension.\n\nGNH India supplies Latanotears as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanotears is a prostaglandin analog used to manage conditions that involve elevated intraocular pressure.\n\nOpen-angle glaucoma: reduces intraocular pressure to prevent optic nerve damage.\nOcular hypertension: lowers eye pressure to reduce the risk of developing glaucoma.

Latanotears may cause a range of ocular and peri‑ocular reactions.\n\nCommon Side Effects:\n- Eye irritation or burning sensation\n- Redness of the conjunctiva\n- Itching or mild discomfort\n- Blurred vision shortly after instillation\n- Increased eyelash length and density\n- Darkening of the iris or peri‑ocular skin pigmentation\n\nSerious or Rare Side Effects:\n- Uveitis or intraocular inflammation\n- Macular edema leading to visual disturbance\n- Severe allergic reaction with swelling or pain\n- Marked hypotony (excessive pressure drop) that may threaten vision

Before using Latanotears, consider the following safety measures.\n\nPregnancy: Category C – use only if the potential benefit justifies the risk.\nBreastfeeding: Caution – safety not established, weigh benefits against potential risks.\nActive ocular infection or inflammation: Avoid use until resolved.\nRecent ocular surgery: Defer use until the surgeon approves.\nMonitor intraocular pressure after initiation to ensure therapeutic response.\nStore below 25°C: keep in the original container, protect from light and moisture.

Latanotears can interact with other ocular medications, affecting efficacy or safety.\n\nMajor Interactions (Avoid):\n- Other prostaglandin analog eye drops: additive IOP‑lowering effect may cause hypotony.\n- Systemic carbonic anhydrase inhibitors: may diminish the IOP‑lowering effect of latanoprost.\n\nModerate Interactions (Monitor Closely):\n- Beta‑blocker eye drops: combined use may produce excessive pressure reduction.\n- Alpha‑agonist eye drops: may increase ocular irritation.\n- Topical corticosteroids: may raise the risk of cataract formation.